3
ICAP

january, 2018

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx

Project Details

Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID). This multicenter study aims to rapidly identify safe and effective treatments for COVID-19. Ambulatory adults who have recently been diagnosed with mild to moderate COVID-19 may be eligible to receive one of several different treatments that are being studied concurrently in this double-blind, placebo-controlled trial.

Soon to begin enrollment

Web Links:
https://clinicaltrials.gov/ct2/show/NCT04885530